Contact Information

IRB Administration Office
[University Hospitals]
Lakeside 1400
11100 Euclid Avenue
Cleveland, OH 44106
MS: LKS 7061
216-844-1529
FAX: 216-844-1547
News & Updates

Current  Archive  
FDA Requirements Regarding IRB Registration – STATUS UPDATE: September 14, 2009
Thursday, September 24, 2009 (389 reads)


Both IRB committees for the UHCMC IRB (IRB00000684 and IRB00001691) are registered per the new Food and Drug Administration (FDA)'s registration requirements as reviewing FDA regulated research. Confirmation of this registration can be found by searching the UHCMC IRB Organizational Information number (IORG0004088) on the HHS Office of Human Research Protections (OHRP) registration system and clicking on the link for "U Hosps Case Med Ctr." Please note that both committees of the UHCMC IRB also review federally funded research and are also registered as such.



Read More
July 1, 2009: Revisions to the “ACTIVITY DETERMINATION FORM (DET)”
Thursday, July 09, 2009 (235 reads)


The “Activity Determination Form” (DET) has been revised to clarify the Department of Health and Human Services (DHHS) Office of Human Research Protections (OHRP) definition of “research” and to remove the stipulation that information gathered from the non-research activity may not be published (to take into account information presented and published from quality improvement projects and case reports, per UHCMC policy).

In addition, clarifications were made to the form’s instructions to state that an investigator must select applicability from all three categories on the form: DHHS (Section A and/or B), Food and Drug Administration (FDA, section C) and HIPAA (Section D) in order for the Center for Clinical Research and Technology to make a determination as to the applicability of the federal regulations pertaining to human subject research.




Read More
July 1, 2009: FDA Requirements Regarding IRB Registration
Thursday, July 09, 2009 (697 reads)


In January, 2009, the Food and Drug Administration (FDA) posted a final rule (effective July 14, 2009) that will require institutional review boards (IRBs) to register through a system maintained by the Department of Health and Human Services (HHS). This registration system is the same system utilized by the HHS Office of Human Research Protections (OHRP) to maintain a list of IRBs which review federally funded research. Any IRBs reviewing clinical investigations regulated by the FDA must be registered in this system by September 14, 2009.

Please note that UHCMC IRB has two IRB committees, both of which are registered in this system. Anyone who requires documentation of this registration may search the OHRP website to confirm current registration status.

The IRB registrations numbers (IRB00000684 and IRB00001691), as well as the HHS Federal Wide Assurance of Compliance number (FWA00003937) can be found on the IRB FAQ webpage, the IRB Statement of Compliance letter, the IRB rosters and the IRB protocol approval letter.




Read More
June 15, 2009: Revisions to the “CHECKLIST FOR NEW PROJECT INVOLVING HUMAN SUBJECTS (N)”
Wednesday, June 24, 2009 (249 reads)


The following administrative revisions have been made to the New Protocol Checklist (N):

  • Question 28b has been revised to request additional information about whether the research will involve the National Institutes of Health (NIH) Genome Wide Association Studies (GWAS) Program.
  • Questions 29 regarding use of investigational drug has been revised to confirm if UHCMC Investigational Drug Services (IDS) is to be utilized as part of the study and to request a copy of the IDS Exemption Request Form.
  • Question 29 has also been revised to request a copy of the IND/IDE correspondence affirming IND/IDE status from either the FDA or the Study Sponsor.
  • Question 35 has been revised to correct the name of the Dahms Clinical research Unit (DCRU).
Please utilize the most current version of the New Protocol Checklist when submitting a new protocol. Failure to utilize the most current version will result in delays in approval process.




Read More
June 15, 2009: New Policy - “Quality Improvement” Activities
Tuesday, June 16, 2009 (150 reads)


A policy has been developed to provide an explanation about “quality improvement/assurance” activities and when IRB review and/or approval is needed. This policy reflects current Federal regulatory guidance disseminated by the Office of Human Research Protections (OHRP).



Read More